Cheryl Lapham

1.6k total citations
20 papers, 1.4k citations indexed

About

Cheryl Lapham is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Cheryl Lapham has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 11 papers in Virology and 4 papers in Infectious Diseases. Recurrent topics in Cheryl Lapham's work include Immune Cell Function and Interaction (12 papers), HIV Research and Treatment (11 papers) and Immunotherapy and Immune Responses (6 papers). Cheryl Lapham is often cited by papers focused on Immune Cell Function and Interaction (12 papers), HIV Research and Treatment (11 papers) and Immunotherapy and Immune Responses (6 papers). Cheryl Lapham collaborates with scholars based in United States. Cheryl Lapham's co-authors include Hana Golding, Marina Zaitseva, Dimiter S. Dimitrov, Jun Ouyang, Nga Y. Nguyen, Bhaskar Chandrasekhar, Howard Mostowski, Andrew Blauvelt, Susan Hester and Yair Argon and has published in prestigious journals such as Science, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Cheryl Lapham

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Lapham United States 14 1.1k 770 263 213 211 20 1.4k
Christine Lekutis United States 13 684 0.7× 587 0.8× 353 1.3× 232 1.1× 26 0.1× 16 1.4k
Concepción Marañón Spain 22 852 0.8× 217 0.3× 528 2.0× 146 0.7× 194 0.9× 48 1.6k
J A Berzofsky United States 15 1.0k 1.0× 280 0.4× 493 1.9× 110 0.5× 196 0.9× 38 1.5k
E M Walker United States 11 597 0.6× 71 0.1× 280 1.1× 192 0.9× 219 1.0× 18 1.3k
B J Gormus United States 18 490 0.5× 713 0.9× 143 0.5× 567 2.7× 136 0.6× 63 1.5k
Els J. M. Hogervorst Netherlands 11 252 0.2× 291 0.4× 277 1.1× 287 1.3× 25 0.1× 13 721
Miriam Lieberman United States 16 453 0.4× 453 0.6× 459 1.7× 321 1.5× 213 1.0× 34 1.4k
Lisa Kierstead United States 17 1.1k 1.0× 561 0.7× 672 2.6× 342 1.6× 482 2.3× 20 1.9k
John L. Dzuris United States 24 1.2k 1.2× 1.1k 1.4× 324 1.2× 309 1.5× 41 0.2× 31 2.0k
A. M. L. Lever United Kingdom 18 387 0.4× 674 0.9× 730 2.8× 338 1.6× 53 0.3× 30 1.5k

Countries citing papers authored by Cheryl Lapham

Since Specialization
Citations

This map shows the geographic impact of Cheryl Lapham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Lapham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Lapham more than expected).

Fields of papers citing papers by Cheryl Lapham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Lapham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Lapham. The network helps show where Cheryl Lapham may publish in the future.

Co-authorship network of co-authors of Cheryl Lapham

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Lapham. A scholar is included among the top collaborators of Cheryl Lapham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Lapham. Cheryl Lapham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lapham, Cheryl, et al.. (2002). CXCR4 heterogeneity in primary cells: possible role of ubiquitination. Journal of Leukocyte Biology. 72(6). 1206–1214. 38 indexed citations
2.
Golding, Basil, Dorothy E. Scott, Liyun Huang, et al.. (2001). Immunity and protection against. Microbes and Infection. 3(1). 43–48. 171 indexed citations
3.
Zaitseva, Marina, Shirley Lee, Cheryl Lapham, et al.. (2000). Interferon γ and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection. Blood. 96(9). 3109–3117. 34 indexed citations
6.
Zaitseva, Marina, Shirley Lee, Cheryl Lapham, et al.. (2000). Interferon γ and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection. Blood. 96(9). 3109–3117. 28 indexed citations
7.
Lapham, Cheryl, et al.. (1999). Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nature Medicine. 5(3). 303–308. 109 indexed citations
8.
Golding, Hana, Jun Ouyang, Marina Zaitseva, et al.. (1999). Increased Association of Glycoprotein 120-CD4 with HIV Type 1 Coreceptors in the Presence of Complex-Enhanced Anti-CD4 Monoclonal Antibodies. AIDS Research and Human Retroviruses. 15(2). 149–159. 5 indexed citations
9.
Zaitseva, Marina, et al.. (1997). Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection. Nature Medicine. 3(12). 1369–1375. 311 indexed citations
11.
Lapham, Cheryl, Jun Ouyang, Bhaskar Chandrasekhar, et al.. (1996). Evidence for Cell-Surface Association Between Fusin and the CD4-gp120 Complex in Human Cell Lines. Science. 274(5287). 602–605. 322 indexed citations
12.
Golding, Hana, Dimiter S. Dimitrov, Jody Manischewitz, et al.. (1995). Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. Journal of Virology. 69(10). 6140–6148. 33 indexed citations
13.
Yewdell, J W, et al.. (1994). MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.. The Journal of Immunology. 152(3). 1163–1170. 79 indexed citations
14.
Bennink, Jack R., Robert Anderson, Igor Bačík, et al.. (1993). Antigen Processing, Where Tumor-Specific T-Cell Responses Begin. Journal of Immunotherapy. 14(3). 202–208. 18 indexed citations
15.
Yewdell, Jonathan W., Robert Anderson, Josephine H. Cox, et al.. (1993). The multiple uses of viruses for studying antigen processing. Seminars in Virology. 4(2). 109–116. 7 indexed citations
16.
Lapham, Cheryl, Igor Bačík, Jonathan W. Yewdell, Kevin P. Kane, & Jack R. Bennink. (1993). Class I molecules retained in the endoplasmic reticulum bind antigenic peptides.. The Journal of Experimental Medicine. 177(6). 1633–1641. 28 indexed citations
17.
Sacks, Leonard, et al.. (1991). A Streptococcal Erythrogenic Toxin Preparation Augments Natural Killer Activity of Peripheral Blood Mononuclear Cells. The Journal of Infectious Diseases. 164(3). 522–526. 4 indexed citations
18.
Burkhardt, Janis K., Susan Hester, Cheryl Lapham, & Yair Argon. (1990). The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments.. The Journal of Cell Biology. 111(6). 2327–2340. 129 indexed citations
19.
Lapham, Cheryl, et al.. (1986). The mechanism of enhancement of natural killer cell activity by soluble streptococcal products. Clinical Immunology and Immunopathology. 40(2). 335–346. 4 indexed citations
20.
Tomar, Russell H., et al.. (1982). Activation of natural killer cells in vitro by a product of β-hemolytic streptococci. Cellular Immunology. 69(2). 388–394. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026